As a bioscience valuation practice, Pathology Associates provides equity and credit analysis of life science companies to regulated institutional investors. We combine “forensic analysis” of clinical data releases and proprietary AI assisted bio-statistic and epidemiologic modeling with input from a wide network of experts.